NervGen Pharma Corp.(TSXV:NGEN) added to S&P/TSX Venture Composite Index
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.1 CAD | +1.94% | +1.94% | -22.22% |
Apr. 17 | NervGen Reports FY 2023 Net Loss of $0.38 Per Share, Provides Operations Update | MT |
Apr. 17 | NervGen Pharma Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-22.22% | 107M | |
+0.17% | 42.19B | |
+10.92% | 42.24B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+5.23% | 24.63B | |
-24.79% | 18.2B | |
+26.69% | 12.01B | |
-3.13% | 11.76B | |
+6.57% | 10.4B |
- Stock Market
- Equities
- NGEN Stock
- News NervGen Pharma Corp.
- NervGen Pharma Corp.(TSXV: NGEN) added to S&P/TSX Venture Composite Index